What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? (Q36364062)

13 August 2017

1 reference

title

What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? (English)

1 reference

13 August 2017

0 references

cardiovascular disease

1 reference

Tayebjee MH

1

1 reference

PubMed ID

16401304

13 August 2017

Lip GY

series ordinal

2

1 reference

PubMed ID

16401304

13 August 2017

MacFadyen RJ

series ordinal

3

1 reference

13 August 2017

1 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

22

1 reference

13 August 2017

12

1 reference

13 August 2017

1628-1635

1 reference

Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Diastolic heart failure: recognition, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Matrix metalloproteinases: they're not just for matrix anymore!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Matrix remodelling enzymes, the protease cascade and glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Matrix metalloproteinases and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Matrix metalloproteinases in human diabetic and nondiabetic vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Monocyte/mesangial cell interactions in high-glucose co-cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01675.X

10.1111/J.1464-5491.2005.01675.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16401304